Metropolitan Life Insurance Company (MetLife)’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-35,953	Closed	-$1.94M	–	2528
2017 Q4	$1.94M	Sell	35,953 -70,733	-66%	-$3.87M	0.03%	565
2017 Q3	$6.09M	Buy	106,686 +76	+0.1%	+$4.45K	0.04%	464
2017 Q2	$6.42M	Buy	106,610 +1,558	+1%	+$88.7K	0.04%	426
2017 Q1	$5.72M	Buy	+105,052	New	+$5.17M	0.04%	501

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s BIVV Position: Q1 2018 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 35,953 shares — an estimated $1.94M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $6.42M in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Metropolitan Life Insurance Company (MetLife) reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 35,953 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $1.94M.
Metropolitan Life Insurance Company (MetLife) first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Metropolitan Life Insurance Company (MetLife)'s Bioverativ Inc. Common Stock position peaked at $6.42M in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2018, filed 15 May 2018.